Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Goodfellow

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
American Journal of Human Genetics|April 21, 2004
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family historyBarbara M Buttin, Matthew A Powell, David G Mutch, et al.
Cancer Research|January 18, 2018
<i>STAT3/PIAS3</i> Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian TubeUksha Saini, Adrian A Suarez, Shan Naidu, et al.
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
Human Mutation|June 28, 2016
MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch RepairChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Science (New York, N.Y.)|June 27, 2009
DICER1 mutations in familial pleuropulmonary blastomaD Ashley Hill, Jennifer Ivanovich, John R Priest, et al.
Gynecologic Oncology|July 15, 2014
A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group StudyMatthew A Powell, Michael W Sill, Paul J Goodfellow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2013
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profilesMelissa K McConechy, Jiarui Ding, Janine Senz, et al.
Neoplasia (New York, N.Y.)|August 21, 2020
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaChristopher S Koivisto, Melodie Parrish, Santosh B Bonala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2013
Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancerYa-Ting Hsu, Fei Gu, Yi-Wen Huang, et al.
JCO Precision Oncology|January 7, 2022
Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective StudyMonica D Levine, Rachel Pearlman, Heather Hampel, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
American Journal of Human Genetics|April 21, 2004
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family historyBarbara M Buttin, Matthew A Powell, David G Mutch, et al.
Cancer Research|January 18, 2018
<i>STAT3/PIAS3</i> Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian TubeUksha Saini, Adrian A Suarez, Shan Naidu, et al.
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
Human Mutation|June 28, 2016
MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch RepairChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Science (New York, N.Y.)|June 27, 2009
DICER1 mutations in familial pleuropulmonary blastomaD Ashley Hill, Jennifer Ivanovich, John R Priest, et al.
Gynecologic Oncology|July 15, 2014
A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group StudyMatthew A Powell, Michael W Sill, Paul J Goodfellow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2013
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profilesMelissa K McConechy, Jiarui Ding, Janine Senz, et al.
Neoplasia (New York, N.Y.)|August 21, 2020
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaChristopher S Koivisto, Melodie Parrish, Santosh B Bonala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2013
Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancerYa-Ting Hsu, Fei Gu, Yi-Wen Huang, et al.
JCO Precision Oncology|January 7, 2022
Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective StudyMonica D Levine, Rachel Pearlman, Heather Hampel, et al.
Pageof 12